Swisher SG , Ajani JA, Chirieac L, Vaporciyan AA, Wu TT, Hunt KK, Correa AM, Komaki R, Rice DC, Walsh GL, Roth JA
Under the Therapeutic Goods Act 1989, all therapeutic goods supplied in Australia must be registered, listed, or supplied through a defined approved pathway
Signs & Symptoms Clinical presentation varies significantly by diabetes type, duration, and degree of glycemic control
The pharmacokinetic parameters were calculated using the mean concentration and Watson LIMS software according to the non-atrioventricular model
Continuous use advantages include maintaining peak benefits without decline periods, avoiding the uncertainty of whether improvements will persist after breaks, simplifying routine through consistency, and potentially maximizing cumulative collagen synthesis through sustained stimulation over months to years